GRAIL Inc Sustainability Reports
GRAIL, Inc. is a healthcare company focused on the early detection of cancer through next-generation sequencing and data science. The company develops and commercializes pioneering multi-cancer early detection blood screening tests, such as its flagship Galleri test.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
LEI: 2549009XSNESW3VE8024
FIGI: BBG01N6CGX05
1 reports from 2024 to 2024